https://prabadinews.com/
  • October 7, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

LDL-C–Lowering Inclisiran May Carry Lower Risk of Diabetes Than Atorvastatin

LDL-C–Lowering Inclisiran May Carry Lower Risk of Diabetes Than Atorvastatin

Inclisiran was found to have a lower risk causing new-onset diabetes compared with other low-density lipoprotein cholesterol (LDL-C)-lowering therapies.

administrator

Related Articles